» Articles » PMID: 34040532

Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells Can Be Protected Against by KLF4-Mediated Upregulation of XCT

Overview
Journal Front Pharmacol
Date 2021 May 27
PMID 34040532
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis, which is characterized by the accumulation of intracellular iron and subsequent lipid peroxidation, is a newly discovered form of regulated cell death and plays an important role in tumor suppression. Herein, we showed that Polyphyllin III, which is a major saponin extracted from rhizomes, exerted its proliferation-inhibitory effect on MDA-MB-231 triple-negative breast cancer cells mainly through ACSL4-mediated lipid peroxidation elevation and ferroptosis induction. ACSL4 deletion partly attenuated Polyphyllin III-induced ferroptosis. Polyphyllin III treatment also induced KLF4-mediated protective upregulation of xCT, which is the negative regulator of ferroptosis. Interestingly, combination with the xCT inhibitor sulfasalazine (SAS) or downregulation of KLF4 sensitized MDA-MB-231 cells to Polyphyllin III. Furthermore, xenograft models, SAS significantly sensitized MDA-MB-231 breast cancer cells to Polyphyllin III, likely by enhancing intracellular lipid peroxidation and ferroptosis. The results of this study collectively demonstrated that Polyphyllin III exerts its anticancer effect by inducing ferroptosis via ACSL4 in MDA-MB-231 breast cancer cells. More importantly, we observed for the first time that KLF4-mediated xCT upregulation serves as negative feedback during ferroptosis progression, which might contribute to drug resistance in cancer treatment.

Citing Articles

Research progress on the use of traditional Chinese medicine to treat diseases by regulating ferroptosis.

Liu S, Yang X, Zheng S, Chen C, Qi L, Xu X Genes Dis. 2025; 12(3):101451.

PMID: 40070365 PMC: 11894312. DOI: 10.1016/j.gendis.2024.101451.


KLF4: a multifunctional nexus connecting tumor progression and immune regulation.

Ju Y, Xiao W, Mathis B, Shi Y Front Immunol. 2025; 16:1514780.

PMID: 39995670 PMC: 11848521. DOI: 10.3389/fimmu.2025.1514780.


Dissection of transcriptome and metabolome insights into the polyphyllin biosynthesis in Paris.

Xu P, Mi Q, Zhang X, Zhang X, Yu M, Gao Y BMC Plant Biol. 2025; 25(1):206.

PMID: 39955498 PMC: 11829371. DOI: 10.1186/s12870-025-06219-0.


Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer.

Peng C, Chen Y, Jiang M Front Oncol. 2025; 14:1499125.

PMID: 39759144 PMC: 11695291. DOI: 10.3389/fonc.2024.1499125.


Broadening horizons: the multifaceted role of ferroptosis in breast cancer.

Ge A, Xiang W, Li Y, Zhao D, Chen J, Daga P Front Immunol. 2024; 15:1455741.

PMID: 39664391 PMC: 11631881. DOI: 10.3389/fimmu.2024.1455741.


References
1.
Timmerman L, Holton T, Yuneva M, Louie R, Padro M, Daemen A . Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013; 24(4):450-65. PMC: 3931310. DOI: 10.1016/j.ccr.2013.08.020. View

2.
Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin S . The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020; 30(2):146-162. PMC: 7015061. DOI: 10.1038/s41422-019-0263-3. View

3.
Lee M, Yuet-Wa J, Kong S, Yu B, Eng-Choon V, Nai-Ching H . Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft. Cancer Biol Ther. 2005; 4(11):1248-54. DOI: 10.4161/cbt.4.11.2136. View

4.
Ghaleb A, Yang V . Krüppel-like factor 4 (KLF4): What we currently know. Gene. 2017; 611:27-37. PMC: 5391259. DOI: 10.1016/j.gene.2017.02.025. View

5.
Yuan H, Li X, Zhang X, Kang R, Tang D . Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016; 478(3):1338-43. DOI: 10.1016/j.bbrc.2016.08.124. View